Benson Relaxation Exercise on Anxiety and Sleep Quality in Psychiatric Service (BREASQPS)
(BREASQPS)
Investigation of the Effect of Benson Relaxation Exercise on Anxiety and Sleep Quality in Inpatients in Psychiatric Service: a Randomized Controlled Study
1 other identifier
interventional
70
0 countries
N/A
Brief Summary
This study was planned to investigate the effect of Benson Relaxation Exercise on anxiety and sleep quality in inpatients in psychiatric ward. The following hypothesis will be tested in the study. H1: Anxiety level of the patients who underwent Benson relaxation exercise is lower than the patients who did not undergo Benson relaxation exercise. H2: The sleep quality of patients who undergo Benson relaxation exercise is better than patients who do not undergo Benson relaxation exercise. The study is designed as a single-blind, randomised controlled trial. The study will be conducted in four psychiatric wards of a private psychiatric hospital in Turkey between 18.11.2024-06.06.2025. Verbal and written informed consent will be obtained from participants or their legal guardians before assignment to study groups. The study will be conducted according to the CONSORT flow diagram (http://www.consort-statement.org/consort-statement/flow-diagram) (2010)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2024
CompletedStudy Start
First participant enrolled
December 23, 2024
CompletedFirst Posted
Study publicly available on registry
December 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2025
CompletedDecember 24, 2024
December 1, 2024
5 months
November 29, 2024
December 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
anxiety level -STAI Forms
anxiety level, the STAI-II forms
up to 6 months
Secondary Outcomes (1)
Sleep quality-Pittsburg Sleep Quality Index (PSQI)
up to 6 months
Study Arms (2)
Intervention Group
EXPERIMENTALSince patients diagnosed with psychotic disorder and schizophrenia have delusions and hallucinations, the effect of some instructions in the Benson relaxation technique on these symptoms cannot be known. Therefore, it was planned to exclude psychosis and schizophrenia patients with delusions and hallucinations from the study.
Control Group
NO INTERVENTIONSince patients diagnosed with psychotic disorder and schizophrenia have delusions and hallucinations, the effect of some instructions in the Benson relaxation technique on these symptoms cannot be known. Therefore, it was planned to exclude psychosis and schizophrenia patients with delusions and hallucinations from the study
Interventions
BRT is one of the behavioural intervention techniques developed by Herbert Benson in 1975. BRT is based on the principle of deep breathing and relaxing all the muscles in the body by choosing a word that is meaningful for the individual and focusing on it. This exercise, which has no side effects on patients and can be applied for patients of all age groups, is more widely used because it is a simple and easy-to-learn method compared to other relaxation methods all the muscles in the body by choosing a word that is meaningful for the individual and focusing on it.
Eligibility Criteria
You may qualify if:
- Patients aged 18 years and over,
- patients being treated for mood, anxiety, obsessive-compulsive disorder and substance use disorder,
- patients with STAI I-II scores between 20 and 59, patients with PSQI score above 5.
You may not qualify if:
- Patients under 18 years of age,
- patients with psychotic disorders with hallucinations and delusions, patients with schizophrenia,
- patients with STAI I-II score below 20 and above 59, patients with PSQI score below 5.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Dr. (Psychiatric Nursing)
Study Record Dates
First Submitted
November 29, 2024
First Posted
December 24, 2024
Study Start
December 23, 2024
Primary Completion
June 2, 2025
Study Completion
December 2, 2025
Last Updated
December 24, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share